Perrigo — which manufactures generic drugs, over-the-counter medications and baby formulas — confirmed the search Tuesday.
The DOJ is investigating several generic drugmakers, including Perrigo, for allegedly colluding to set prices artificially high, according to USA Today.
“As has been previously disclosed by a number of companies, the antitrust division has been looking at industrywide pricing practices,” Perrigo said in a statement. “The company is taking this investigation seriously and is cooperating with the appropriate authorities.”
More articles on supply chain:
The key to supply chain efficiency: Aligning clinical and supply chain staff
US drug spending to hit $610B by 2021: 4 report findings
Physicians prescribe fewer branded drugs when hospitals limit drug rep interactions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
